Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

The impact of vaccination and new SARS‐CoV‐2 variants on peri‐operative outcomes is
unclear. We aimed to update previously published consensus recommendations on timing …

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …

Guidance for the timing of surgery following SARS‐CoV‐2 infection needed reassessment
given widespread vaccination, less virulent variants, contemporary evidence and a need to …

Early in the coronavirus disease 2019 (COVID-19) pandemic, global governing bodies
prioritized transmissibility-based precautions and hospital capacity as the foundation for …

Three years into the coronavirus disease (COVID)-19 pandemic and the world is still
struggling with the aftermath of this global health crisis. In Brazil, we are witnessing serious …

Coronavirus disease 2019 is characterized by its severe respiratory effects. Data early on
indicated an increased risk of mortality in patients with cardiovascular comorbidities. Early …

Background: Surgical procedures performed on patients with recent exposure to COVID-19
infection have been associated with increased mortality risk in previous studies. Accordingly …

Background: During the coronavirus disease (COVID)-19 pandemic several drugs were
used to manage the patients mainly those with a severe phenotype. Potential drugs were …